Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.24
-0.03-2.36%
At close: -
$1.24
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
PMV Pharma Analyst Ratings and Price Targets | NASDAQ:PMVP | Benzinga
PMV Pharmaceuticals Inc has a consensus price target of $10.5 based on the ratings of 6 analysts. The high is $25 issued by Goldman Sachs on May 24, 2022. The low is $5 issued by HC Wainwright & Co. on March 20, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on March 20, 2025, August 20, 2024, and May 30, 2024, respectively. With an average price target of $5 between HC Wainwright & Co., there's an implied 303.23% upside for PMV Pharmaceuticals Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Craig-Hallum
Jefferies
Ladenburg Thalmann
Oppenheimer
1calculated from analyst ratings
Analyst Ratings for PMV Pharma
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/20/2025 | Buy Now | 303.23% | HC Wainwright & Co. | Robert Burns42% | $5 → $5 | Reiterates | Buy → Buy | Get Alert |
| 08/20/2024 | Buy Now | 303.23% | HC Wainwright & Co. | Robert Burns42% | $5 → $5 | Reiterates | Buy → Buy | Get Alert |
| 05/30/2024 | Buy Now | 303.23% | HC Wainwright & Co. | Robert Burns42% | $5 → $5 | Reiterates | Buy → Buy | Get Alert |
| 05/14/2024 | Buy Now | 303.23% | HC Wainwright & Co. | Robert Burns42% | $5 → $5 | Reiterates | Buy → Buy | Get Alert |
| 05/13/2024 | Buy Now | 383.87% | Craig-Hallum | Albert Lowe21% | → $6 | Initiates | → Buy | Get Alert |
| 04/12/2024 | Buy Now | 303.23% | Jefferies | Kambiz Yazdi60% | → $5 | Initiates | → Buy | Get Alert |
| 03/07/2024 | Buy Now | 303.23% | HC Wainwright & Co. | Robert Burns42% | $5 → $5 | Reiterates | Buy → Buy | Get Alert |
| 12/27/2023 | Buy Now | 464.52% | Ladenburg Thalmann | Aydin Huseynov36% | → $7 | Initiates | → Buy | Get Alert |
| 10/16/2023 | Buy Now | 303.23% | HC Wainwright & Co. | Robert Burns42% | $29 → $5 | Maintains | Buy | Get Alert |
| 08/11/2023 | Buy Now | 2238.71% | HC Wainwright & Co. | Robert Burns42% | $35 → $29 | Maintains | Buy | Get Alert |
| 05/17/2023 | Buy Now | 2722.58% | HC Wainwright & Co. | Robert Burns42% | → $35 | Reiterates | Buy → Buy | Get Alert |
| 05/11/2023 | Buy Now | 1109.68% | Oppenheimer | Jeff Jones32% | → $15 | Reiterates | Outperform → Outperform | Get Alert |
| 03/20/2023 | Buy Now | 2722.58% | HC Wainwright & Co. | Robert Burns42% | $36 → $35 | Maintains | Buy | Get Alert |
| 03/02/2023 | Buy Now | 1109.68% | Oppenheimer | Jeff Jones32% | $28 → $15 | Maintains | Outperform | Get Alert |
| 11/17/2022 | Buy Now | 2803.23% | HC Wainwright & Co. | Robert Burns42% | $63 → $36 | Maintains | Buy | Get Alert |
| 06/09/2022 | Buy Now | 2561.29% | Oppenheimer | Jeff Jones32% | $30 → $33 | Maintains | Outperform | Get Alert |
| 05/24/2022 | Buy Now | 1916.13% | Goldman Sachs | Paul Choi57% | $43 → $25 | Maintains | Buy | Get Alert |
FAQ
What is the target price for PMV Pharma (PMVP) stock?
The latest price target for PMV Pharma (NASDAQ:PMVP) was reported by HC Wainwright & Co. on March 20, 2025. The analyst firm set a price target for $5.00 expecting PMVP to rise to within 12 months (a possible 303.23% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for PMV Pharma (PMVP)?
The latest analyst rating for PMV Pharma (NASDAQ:PMVP) was provided by HC Wainwright & Co., and PMV Pharma reiterated their buy rating.
When was the last upgrade for PMV Pharma (PMVP)?
There is no last upgrade for PMV Pharma
When was the last downgrade for PMV Pharma (PMVP)?
There is no last downgrade for PMV Pharma.
When is the next analyst rating going to be posted or updated for PMV Pharma (PMVP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PMV Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PMV Pharma was filed on March 20, 2025 so you should expect the next rating to be made available sometime around March 20, 2026.
Is the Analyst Rating PMV Pharma (PMVP) correct?
While ratings are subjective and will change, the latest PMV Pharma (PMVP) rating was a reiterated with a price target of $5.00 to $5.00. The current price PMV Pharma (PMVP) is trading at is $1.24, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.